1-155238596-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM5PP2PP3_StrongPP5
The NM_000157.4(GBA1):c.509G>A(p.Arg170His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,461,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R170C) has been classified as Pathogenic.
Frequency
Consequence
NM_000157.4 missense
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Gaucher diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Gaucher disease perinatal lethalInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Gaucher disease type IInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Gaucher disease type IIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Gaucher disease type IIIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000157.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GBA1 | NM_000157.4 | MANE Select | c.509G>A | p.Arg170His | missense | Exon 5 of 11 | NP_000148.2 | ||
| GBA1 | NM_001005741.3 | c.509G>A | p.Arg170His | missense | Exon 6 of 12 | NP_001005741.1 | |||
| GBA1 | NM_001005742.3 | c.509G>A | p.Arg170His | missense | Exon 6 of 12 | NP_001005742.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GBA1 | ENST00000368373.8 | TSL:1 MANE Select | c.509G>A | p.Arg170His | missense | Exon 5 of 11 | ENSP00000357357.3 | ||
| GBA1 | ENST00000327247.9 | TSL:1 | c.509G>A | p.Arg170His | missense | Exon 6 of 12 | ENSP00000314508.5 | ||
| GBA1 | ENST00000427500.7 | TSL:2 | c.362G>A | p.Arg121His | missense | Exon 4 of 10 | ENSP00000402577.2 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251178 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461658Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727142 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Gaucher disease type II;C0268251:Gaucher disease type III;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I Pathogenic:1
not specified Uncertain:1
Variant summary: GBA c.509G>A (p.Arg170His), also referred to as p.R131H, results in a non-conservative amino acid change located in the Glycosyl hydrolase family 30, TIM-barrel domain (IPR033453) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251178 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.509G>A has been reported in the literature in at least two individuals affected with Gaucher Disease (e.g. Liao_2014, Hassan_2018). At least one other variant causing a different missense change at the same amino acid residue has been classified as pathogenic in ClinVar (e.g. c.508C>T, p.Arg170Cys; ClinVar: 93453). These data do not allow any strong conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at